Welcome, Guest
Username: Password: Remember me
CYTX Financial performance development
  • Page:
  • 1

TOPIC: SABBY adds 14 million shares

SABBY adds 14 million shares 03 Apr 2016 16:24 #6766

  • CalhounDoppelganger
  • CalhounDoppelganger's Avatar Topic Author
  • Offline
  • Gold Boarder
  • Gold Boarder
  • Posts: 160
  • Thank you received: 20
www.streetedition.net/sabby-management-buys-2-7-million-stake-in-cytori-therapeutics-inc-cytx/6490936/


April 3rd 2016

Cytori Therapeutics Inc (CYTX) : Sabby Management scooped up 14,208,417 additional shares in Cytori Therapeutics Inc during the Q4 period, according to a recent disclosure to the SEC. The investment management firm now holds a total of 17,150,297 shares of Cytori Therapeutics Inc which is valued at $2.7 Million.Cytori Therapeutics Inc makes up approximately 0.43% of Sabby Management’s portfolio.



Other Hedge Funds, Including , Mariner Wealth Advisors added CYTX to its portfolio by purchasing 12,000 company shares during the Fourth Quarter which is valued at $1,920.Geode Capital Management boosted its stake in CYTX during the Q4 period, The investment management firm added 28,955 additional shares and now holds a total of 906,954 shares of Cytori Therapeutics Inc which is valued at $145,113. Lpl Financial added CYTX to its portfolio by purchasing 21,793 company shares during the Fourth Quarter which is valued at $6,974.

On the company’s financial health, Cytori Therapeutics Inc reported $-0.03 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Mar 3, 2016. Analyst had a consensus of $-0.04. The company had revenue of $1.56 million for the quarter, compared to analysts expectations of $3.20 million. The company’s revenue was down -36.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $-0.08 EPS.

Cytori Therapeutics Inc closed down -0.0005 points or -0.25% at $0.2025 with 13,27,696 shares getting traded on Wednesday. Post opening the session at $0.203, the shares hit an intraday low of $0.197 and an intraday high of $0.21 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

Cytori Therapeutics Inc. (Cytori) is a biotechnology company involved in the development of treatments and devices for a range of disorders using cells as a key part of the therapy. The Company is engaged in developing primary product Cytori Cell Therapy for patients with scleroderma hand dysfunction orthopedic disorders cardiovascular disease urinary incontinence and thermal burns combined with radiation injury. The Company commercializes the Celution System under select medical device approvals clearances and registrations to research customers developing new therapeutic applications for Cytori Cell Therapy in Europe Japan and other regions. The Company offers ECCO-50 a cure for knee osteoarthritis which is in ECCO-50 Phase IIA/B of development. It offers ECCI-50 a cure for urinary incontinence which is in Phase II/III of development. The Company is also developing DCCT-10 a cure for cutaneous thermal injury.

Please Log in or Create an account to join the conversation.

SABBY adds 14 million shares 04 Apr 2016 01:13 #6767

  • fas
  • fas's Avatar
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3295
  • Thank you received: 1110
This is a typical example of "how to produce" a one page article from old- and stale filing information. :yep:

Sabby´s holdings were already reported February 15th and a 13G filing made accordingly. Most of these shares were most likely part of the 35 Mio freebies shares issued on December 18 2015 and the big question of course, how many still remain in port as of today? :whistle:

What I liked most out of the article:

Other Hedge Funds, Including , Mariner Wealth Advisors added CYTX to its portfolio by purchasing 12,000 company shares during the Fourth Quarter which is valued at $1,920



buaww,, :joy: :joy: buaww :joy: :joy:

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

SABBY adds 14 million shares 04 Apr 2016 07:16 #6769

  • DOV
  • DOV's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 347
  • Thank you received: 194
"scooped up" or traded warrants for stock in Q4 and sold most of them in the first few weeks of January????

Please Log in or Create an account to join the conversation.

SABBY adds 14 million shares 04 Apr 2016 09:00 #6770

  • myownhedgefund
  • myownhedgefund's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 2761
  • Thank you received: 199
Yeah, this appeared on the YMB last night.

Hardly news...doubtful many remain.

I think some forget another aspect of the R/S is that it opens up a wider field of institutions who can buy.

Please Log in or Create an account to join the conversation.

  • Page:
  • 1
Time to create page: 0.091 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites